Where does Integrated Endoscopy, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Integrated Endoscopy, Inc. ranks #24,567 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Integrated Endoscopy, Inc. hold?

Integrated Endoscopy, Inc. holds 11 US utility patents granted between 2019 and 2025, spanning 4 technology areas.

What is Integrated Endoscopy, Inc.'s Innovation Score?

Integrated Endoscopy, Inc. has an Innovation Score of 29.3 out of 100 (30th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Integrated Endoscopy, Inc. focus on?

Integrated Endoscopy, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 7 patents, ranking #2,341 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Integrated Endoscopy, Inc.'s patent grant rate increasing or decreasing?

Integrated Endoscopy, Inc.'s recent grant velocity is +250% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Integrated Endoscopy, Inc.'s patents?

Integrated Endoscopy, Inc.'s patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Integrated Endoscopy, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Integrated Endoscopy, Inc.

USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Integrated ranks #24,567 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 4 technology areas.

#24,567
of 49,997 US assignees by volume: 30th percentile
by Innovation Score (29.3/100): 13.8
avg claims per patent: +250%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24567 · US Corporation #24,567 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,567/49,997
PHOTO-FINISH Instant Care
CPC-NARROW A61B · 4 areas
INNOV-THIN 29.3/100
CLAIMS-RICH 13.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +250% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Instant Care, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Integrated’s 29.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (29%) Velocity 5.3 pts (18%) Breadth 7.1 pts (24%) Claim depth 8.3 pts (28%)

Qualcomm Incorporated · highest

85
Integrated Endoscopy · this assignee

29
3D Lighting… · lowest

7

What this shows Integrated's Innovation Score is 29.3/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Integrated?

Each dot is one of Integrated’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Integrated’s own 13.8 claims/patent is at or below the 15.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Integrated vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Integrated's grants concentrate

Integrated Endoscopy, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 63.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (4 grants) versus a trough of 2 in 2019. By volume, Integrated sits between Instant Care, Inc. and International Stem Cell Corporation.

Integrated's three-year grant acceleration

Integrated Endoscopy, Inc. shows 4 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Instant Care

11
Institute of Chin…

11
Institute of Geol…

11
Instrumentmail

11
Integrityware

11
Intelligent Virus…

11
International Spi…

11
International Ste…

11
Integrated Endosc… ◀

11

What this shows Integrated holds 11 patents at rank #24,568, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Integrated

By rank, the assignees closest to #24,568 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Integrated's primary technology class.

Integrated's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 30th percentile higher than 30% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Integrated Endoscopy, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	2	18.2%
2021	3	27.3%
2023	4	36.4%
2025partial year	2	18.2%

Which technologies does Integrated Endoscopy, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 7

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

G02B - Optical Elements, Systems OR Apparatus 2

H04N - Pictorial Communication, e.g. Television 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Integrated Endoscopy, Inc.'s patent record in context - here's where to go next.

Integrated Endoscopy, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 63.6% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #24,567 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Integrated Endoscopy, Inc. against Instant Care, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.